Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Palbociclib|DRUG: Trastuzumab|DRUG: Endocrine therapy|DRUG: Chemotherapy|DRUG: Antibody-Drug Conjugates
Sponsor: SOLTI Breast Cancer Research Group